<DOC>
	<DOCNO>NCT00708071</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy safety fibrin sealant 4 IU/mL thrombin , vapor heat , solvent detergent treat ( FS VH S/D 4 ) use reduce early postoperative bruising participant undergo rhytidectomy ( face-lift ) .</brief_summary>
	<brief_title>Efficacy Safety Study Fibrin Sealant With 4 IU/mL Thrombin , Vapor Heated , Solvent Detergent Treated ( FS VH S/D 4 ) Face-Lift Procedures</brief_title>
	<detailed_description />
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<mesh_term>Aprotinin</mesh_term>
	<criteria>Subjects plan facial rhytidectomy Subjects read , understand sign write informed consent Healthy female male subject determine investigator use standard preoperative assessment include laboratory test ECG Subjects 1875 year old , inclusively Subjects able willing comply protocol requirement Female subject childbearing potential negative urine serum pregnancy test within 72 hour surgery Pregnant lactate woman Subjects undergone previous facelift surgery Subjects undergo abbreviate facelift procedure deep plane procedure , minimal undermining procedure , thread lift , minimal access cranial suspension Subjects indicate concurrent facial surgery operation ( e.g . forehead plasty , blepharoplasty , rhinoplasty , buccal fat removal , filler injection include fat injection , lip augmentation , skin resurface procedure etc . ) Subjects indicate additional procedure operation ( e.g. , liposuction , mastoplasty etc . ) Subjects prior silicone injection face ( Botox and/or Restylane allow ) Subjects consider investigator smoker Subjects ecchymosis and/or edema face day 0 , prior surgery Subjects know ( document ) bleed coagulation disorder Subjects currently treat anticoagulant Subjects treat Aspirin last 7 day use Nonsteroidal antiinflammatory drug ( NSAIDs ) within last 7 day prior surgery Subjects vascular disorder , cardiovascular disease , and/or uncontrolled hypertension Subjects diabetes mellitus Subjects history BellÂ´s palsy Subjects connective tissue disorder Subjects document history pathologically pharmacologically induce immune deficiency Subjects receive systemic corticosteroid treatment chronic condition within 2 30 day prior surgery Subjects know sensitivity fibrin sealant Subjects know psychiatric disorder ( e.g. , depression , obsessive compulsive disorder , anxiety , eat disorder , etc ) Subjects participate another clinical study within 30 day prior study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>